ANG Lifesciences India share news, announcements and annual reports
BSE: 540694Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹34.40.
30 Oct: open ₹36.00, high ₹36.00, low ₹30.60
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹42 Cr3,715th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −22.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −6.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.47
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,239
ANG Lifesciences India has 374 announcements on record, routine notices left out; none in the 30 days to 2 Nov 2026, the latest on 1 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.ANG Lifesciences India quarterly results
The board met on 14 Aug 2026 to consider quarterly results
Notice filed 7 Aug 2026
ANG Lifesciences India annual reports, presentations and earnings calls
The company's own documents, latest first.ANG Lifesciences India financials, year by year
Annual reports9
- Annual report, year to Mar 20267 Sep 2026
- Annual report, year to Mar 20256 Sep 2025
- Annual report, year to Mar 20247 Sep 2024
- Annual report, year to Mar 202315 Sep 2023
- Annual report, year to Mar 20227 Sep 2022
4 earlier reports
- Annual report, year to Mar 202128 Oct 2021
- Annual report, year to Mar 202012 Dec 2020
- Annual report, year to Mar 201910 Sep 2019
- Annual report, year to Mar 201829 Sep 2018
Investor presentations4
- We hereby enclosed the Investor Presentation of ANG Lifesciences India Limited.14 Aug 2022
- EARNING PRESENTATION H1 FY2226 Oct 2021
- We hereby enclosed the Investor Presentation of ANG Lifesciences India Limited. ....6 Sep 2021
- Please find enclosed herewith the Investor Presentation of ANG Lifesciences India Limited for Half year and Financial Year ended March 2019.14 Jun 2019
ANG Lifesciences India share news and announcements
Newest first. Page 1 of 8.
Oct 2026
1 Oct · Meeting
Sep 2026
30 Sep · Management
7 Sep · Meeting
7 Sep · Corporate action
7 Sep · Meeting
Aug 2026
14 Aug · Results
7 Aug · Board meeting
Meeting on 14 Aug 2026: quarterly results
May 2026
30 May · Results
22 May · Board meeting
Meeting on 30 May 2026: audited results
Apr 2026
10 Apr · Legal
Exchange has sought clarification from ANG Lifesciences India Ltd on April 9, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Feb 2026
14 Feb · Results
5 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Nov 2025
6 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Oct 2025
1 Oct · Meeting
Sep 2025
30 Sep · Management
12 Sep · Legal
12 Sep · Legal
Exchange has sought clarification from ANG Lifesciences India Ltd on September 12, 2025 with reference to significant movement in price, in order to ensure that investors have latest ....6 Sep · Meeting
6 Sep · Corporate action
6 Sep · Meeting
Aug 2025
6 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results
May 2025
30 May · Results
30 May · Board meeting
22 May · Board meeting
Meeting on 30 May 2025: audited results
Mar 2025
Feb 2025
14 Feb · Results
6 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
Dec 2024
16 Dec · Management
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 1 Oct 2026Board or managers changeddown 2.00%−1.0 pts vs Nifty 500market median 0.0% · five sessions −9.6% (−7.5 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 17 Dec 2024Board or managers changeddown 0.78%+0.3 pts vs Nifty 500market median 0.0% · five sessions −4.3% (−0.2 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 16 Aug 2024Board or managers changeddown 1.09%−2.8 pts vs Nifty 500market median 0.0% · five sessions −2.5% (−5.8 pts vs Nifty 500) · volume 1.7× usual · The announcement
- 14 Jun 2024Board or managers changeddown 2.31%−2.9 pts vs Nifty 500market median 0.0% · five sessions −2.2% (−2.9 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 15 Nov 2023Board or managers changeddown 6.22%−7.3 pts vs Nifty 500market median 0.0% · five sessions −6.7% (−8.5 pts vs Nifty 500) · volume 8.1× usual · The announcement
- 16 Oct 2023Board or managers changeddown 1.70%−1.7 pts vs Nifty 500market median 0.0% · five sessions −2.4% (−1.4 pts vs Nifty 500) · volume 2.1× usual · The announcement
- 12 Oct 2023Board or managers changeddown 0.45%−0.5 pts vs Nifty 500market median 0.0% · five sessions −1.0% (−0.7 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 6 Dec 2022Board or managers changeddown 4.19%−3.9 pts vs Nifty 500market median 0.0% · five sessions −8.2% (−7.4 pts vs Nifty 500) · volume 0.8× usual · The announcement
- 6 Sep 2022Credit ratingdown 1.64%−1.8 pts vs Nifty 500market median 0.0% · five sessions +28.4% (+26.6 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 26 Oct 2021Dividendup 4.99%+3.9 pts vs Nifty 500market median 0.0% · five sessions +27.6% (+27.8 pts vs Nifty 500) · volume 0.5× usual · The announcement
9 earlier announcements
- 18 Oct 2021Credit ratingup 2.36%+1.6 pts vs Nifty 500market median 0.0% · five sessions +5.4% (+7.7 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 4 Oct 2021Dividendup 5.00%+3.9 pts vs Nifty 500market median 0.0% · five sessions +17.2% (+14.8 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 9 Aug 2021Board or managers changedup 5.00%+5.1 pts vs Nifty 500market median 0.0% · five sessions +27.4% (+26.6 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 8 Jun 2021Credit ratingup 8.24%+7.5 pts vs Nifty 500market median 0.0% · five sessions +10.5% (+9.3 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 23 Jul 2020Board or managers changeddown 7.14%−8.6 pts vs Nifty 500market median 0.0% · five sessions −1.3% (−1.9 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 22 Jun 2020Board or managers changeddown 8.00%−12.1 pts vs Nifty 500market median 0.0% · five sessions +2.5% (−2.5 pts vs Nifty 500) · volume 1.2× usual · The announcement
- 20 Feb 2019Board or managers changeddown 0.30%+0.2 pts vs Nifty 500market median 0.0% · five sessions −6.7% (−7.3 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 18 Jun 2018Credit ratingdown 3.31%−3.0 pts vs Nifty 500market median 0.0% · five sessions +0.6% (+1.1 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 23 May 2018Dividendup 0.38%+1.2 pts vs Nifty 500market median 0.0% · five sessions −3.8% (−5.6 pts vs Nifty 500) · volume 0.8× usual · The announcement
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Net change in cash | Year to date to Sep 2025 | Consolidated | 0.13 | −0.03 | −122.0% | 14 Nov 2025 | 10 Jan 2026 |
| Total income | Quarter to Jun 2022 | Standalone | 71.68 | 71.68 | 0.0% | 6 Sep 2022 | 25 Nov 2022 |
| Materials used | Quarter to Jun 2022 | Standalone | 48.49 | 48.49 | 0.0% | 6 Sep 2022 | 25 Nov 2022 |
| Employee costs | Quarter to Jun 2022 | Standalone | 5.49 | 10.49 | +91.1% | 6 Sep 2022 | 25 Nov 2022 |
| Finance costs | Quarter to Jun 2022 | Standalone | 3.17 | 3.17 | 0.0% | 6 Sep 2022 | 25 Nov 2022 |
| Depreciation and amortisation | Quarter to Jun 2022 | Standalone | 1.88 | 1.88 | 0.0% | 6 Sep 2022 | 25 Nov 2022 |
| Other expenses | Quarter to Jun 2022 | Standalone | 7.79 | 7.79 | 0.0% | 6 Sep 2022 | 25 Nov 2022 |
| Total expenses | Quarter to Jun 2022 | Standalone | 65.33 | 70.33 | +7.7% | 6 Sep 2022 | 25 Nov 2022 |
| Profit before tax | Quarter to Jun 2022 | Standalone | 6.35 | 1.35 | −78.8% | 6 Sep 2022 | 25 Nov 2022 |
| Tax | Quarter to Jun 2022 | Standalone | 3.01 | 3.01 | 0.0% | 6 Sep 2022 | 25 Nov 2022 |